FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns an agent containing immunoglobulins, aims at prevention and therapy of respiratory infections of viral and bacterial aetiology.
EFFECT: invention provides effective local complex etiotropic action of the agent in pathological processes caused by microbial and viral associations ensured by a combination of specific antibodies being of various immunoglobulin isotypes (classes).
3 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PERTUSSIS IN CHILDREN UNDER AGE OF THREE YEARS | 2014 |
|
RU2542377C1 |
| METHOD FOR OBTAINING IMMUNOGLOBULIN PREPARATION FOR EXTERNAL APPLICATION | 2015 |
|
RU2616266C1 |
| METHOD TO OBTAIN IMMUNOGLOBULIN PRODUCT | 1993 |
|
RU2073525C1 |
| IMMUNOGLOBULIN MARKER BASE FOR IMMUNOBIOLOGICAL PREPARATIONS AND WAY OF ITS RECEPTION, SUPPOSITORIES AND OINTMENT FOR PREVENTION AND THERAPY OF BACTERIEMIC AND VIRUS DISEASES | 2007 |
|
RU2361612C1 |
| MULTICOMPONENT VACCINE FOR IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY OF DISEASES CAUSED BY OPPORTUNISTIC PATHOGENS | 2022 |
|
RU2786222C1 |
| COMPLEX ACTION MEDICATION AND METHOD OF ITS PRODUCTION | 2012 |
|
RU2519553C1 |
| MEDICINAL ANTIGEN CARRIER ENABLING TRANSMUCOSAL AND TRANSDERMAL ADMINISTRATION, METHOD OF MUCOSAL IMMUNITY INDUCTION, MUCOSAL VACCINE AND RELATED DRUG DELIVERY SYSTEM | 2005 |
|
RU2396090C2 |
| APPLICATION OF ADSORBED DRONE BROOD HOMOGENATE AND GROUP D VITAMINS AND/OR THEIR ACTIVE METABOLITES FOR PREVENTION AND TREATMENT OF ACUTE RESPIRATORY DISEASES AND FLU | 2013 |
|
RU2564111C9 |
| METHOD FOR DETECTING ANTIBODIES - CLASS G IMMUNOGLOBULINS IN BLOOD SERUM TO PATHOGENS OF SEVERE ACUTE RESPIRATORY VIRAL INFECTIONS, INCLUDING SARS-COV-2, WITH SIMULTANEOUS PROGNOSIS OF COVID-19 SEVERITY, BASED ON HYDROGEL BIOCHIP | 2020 |
|
RU2746815C1 |
| METHOD OF CONVEYING BIOACTIVE AGENT TO ANIMAL FOR INITIATING IMMUNE RESPONSE | 1989 |
|
RU2127118C1 |
